UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 540

Sortiert nach

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Frontiers in pharmacology, 2018-05, Vol.9, p.482-482

2018

Volltextzugriff (PDF)

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Neuropsychopharmacology (New York, N.Y.), 2010-02, Vol.35 (3), p.764-774

2010

Volltextzugriff (PDF)

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects

PloS one, 2016-07, Vol.11 (7), p.e0158779

2016

Volltextzugriff (PDF)

Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial

JAMA psychiatry (Chicago, Ill.), 2013-07, Vol.70 (7), p.668

2013

Volltextzugriff (PDF)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Mediators of Inflammation, 2015-01, Vol.2015 (1), p.538670-538670

2015

Volltextzugriff (PDF)

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa

CNS & neurological disorders drug targets, 2014-01, Vol.13 (6), p.953

2014

Volltextzugriff (PDF)

Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release

Neurotoxicology (Park Forest South), 2015-09, Vol.50, p.116-121

2015

Volltextzugriff (PDF)

Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies

Current pharmaceutical design, 2012-11, Vol.18 (32), p.5045

2012

Volltextzugriff (PDF)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia

Frontiers in pharmacology, 2018-08, Vol.9, p.901-901

2018

Volltextzugriff (PDF)

Anxiolytic-like effect of oxytocin in the simulated public speaking test

Journal of psychopharmacology (Oxford), 2012-04, Vol.26 (4), p.497-504

2012

Volltextzugriff (PDF)

Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder

Movement disorders, 2021-07, Vol.36 (7), p.1711-1715

2021

Volltextzugriff (PDF)

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis

European journal of pharmacology, 2012-12, Vol.697 (1-3), p.158-164

2012

Volltextzugriff (PDF)

Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus

Progress in neuro-psychopharmacology & biological psychiatry, 2009-11, Vol.33 (8), p.1425-1430

2009

Volltextzugriff (PDF)

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor

European journal of pharmacology, 2012-03, Vol.678 (1-3), p.78-85

2012

Volltextzugriff (PDF)

Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users

Journal of psychiatric research, 2014-04, Vol.51, p.68-78

2014

Volltextzugriff (PDF)

Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

Journal of Neural Transmission, 2010-10, Vol.117 (10), p.1131-1137

2010

Volltextzugriff (PDF)

The effect of cannabis on perception of time: a critical review

Current pharmaceutical design, 2012-11, Vol.18 (32), p.4915

2012

Volltextzugriff (PDF)

Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers

Current opinion in psychiatry, 2020-05, Vol.33 (3), p.250

2020

Volltextzugriff (PDF)

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

Frontiers in pharmacology, 2016-09, Vol.7, p.343-343

2016

Volltextzugriff (PDF)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

Frontiers in immunology, 2018-09, Vol.9, p.2009-2009

2018

Volltextzugriff (PDF)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans

Cannabis and cannabinoid research, 2017, Vol.2 (1), p.81-86

2017

Volltextzugriff (PDF)

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice

IBRO neuroscience reports, 2024-12, Vol.17, p.87-95

2024

Volltextzugriff (PDF)

Adhesio interthalamica and cavum septum pellucidum in mesial temporal lobe epilepsy

Brain imaging and behavior, 2016-09, Vol.10 (3), p.849-856

2016

Volltextzugriff (PDF)

Laboratory, clinical and therapeutic features of respiratory panic disorder subtype

CNS & neurological disorders drug targets, 2015-01, Vol.14 (5), p.627

2015

Volltextzugriff (PDF)

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

Revista brasileira de psiquiatria, 2019-01, Vol.41 (1), p.9-14

2019

Volltextzugriff (PDF)

1 – 25 von 540

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(502)
Mit Volltextzugriff
(445)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects

Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa

Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release

Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia

Anxiolytic-like effect of oxytocin in the simulated public speaking test

Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis

Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor

Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users

Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

The effect of cannabis on perception of time: a critical review

Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice

Adhesio interthalamica and cavum septum pellucidum in mesial temporal lobe epilepsy

Laboratory, clinical and therapeutic features of respiratory panic disorder subtype

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

Suchergebnisse filtern